神经刺激设备市场－全球产业规模、份额、趋势、机会和预测，按类型、应用、地区和竞争格局划分，2020-2030年预测

2024年全球神经刺激设备市场规模为60.7亿美元，预计2030年将以12.10%的复合年增长率成长至120.5亿美元。神经刺激设备是一种特殊的医疗技术，它透过向目标神经或神经通路传递可控的电脉衝来调节神经系统内的活动，从而为各种慢性疾病提供治疗干预。该市场的主要驱动力是全球神经系统疾病和慢性疼痛的盛行率不断上升，以及全球人口老化加剧了此类疾病的易感性。此外，患者和临床医生越来越倾向于选择微创治疗方案而非传统的药物治疗方法，也进一步推动了该市场的发展。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球神经刺激设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（脊髓刺激器、深部脑部刺激器、荐神经刺激器、迷走神经刺激器、其他）
  • 依应用领域（疼痛管理、听力丧失、尿失禁、帕金森氏症、癫痫、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美神经刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲神经刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区神经刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲神经刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲神经刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球神经刺激设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Boston Scientific Corporation
• Medtronic PLC
• Abbott Laboratories Inc.
• Nevro Corp.
• Liva Nova PLC
• Axonics Modulation Technologies Inc.
• Neuropace Inc.
• EndoStim Inc.
• NDI Medical LLC
• Neuronetics Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Neurostimulation Devices Market, valued at USD 6.07 Billion in 2024, is projected to experience a CAGR of 12.10% to reach USD 12.05 Billion by 2030. Neurostimulation devices are specialized medical technologies that deliver controlled electrical impulses to targeted nerves or neural pathways to modulate activity within the nervous system, offering therapeutic intervention for various chronic conditions. This market is fundamentally driven by the escalating global prevalence of neurological disorders and chronic pain conditions, coupled with an aging worldwide population more susceptible to such ailments. Further impetus comes from the increasing patient and clinician preference for minimally invasive treatment alternatives over conventional pharmacological approaches.

Key Market Drivers

The rising burden of neurological and chronic pain disorders significantly drives the global neurostimulation devices market. An escalating number of individuals afflicted with conditions such as neuropathic pain, epilepsy, and movement disorders creates a substantial and growing patient population requiring advanced therapeutic interventions. Neurostimulation offers a viable alternative or adjunct to pharmacological treatments, which may have efficacy limitations. According to "A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors," published in the journal BMC Public Health in September 2023, the overall unweighted prevalence of reported pain for the total combined sample was 28%. This high disease burden necessitates effective and durable treatment options, directly stimulating the adoption and development of neurostimulation technologies.

Key Market Challenges

The substantial cost associated with neurostimulation devices and their implantation procedures, alongside complex reimbursement landscapes, represents a significant challenging factor. This financial barrier directly hampers the growth of the Global Neurostimulation Devices Market by limiting patient access and adoption. High upfront expenses for both the devices and the specialized surgical procedures render these therapies inaccessible for many individuals and strain healthcare budgets globally.

Key Market Trends

Advanced miniaturization and wireless connectivity are significantly influencing the Global Neurostimulation Devices Market by enhancing patient comfort and discretion. Smaller implants and wireless features reduce invasive procedures and simplify remote management, fostering long-term therapy adherence. This innovative momentum is substantial across medical technology; MedTech Europe reported over 15,700 patent applications filed with the European Patent Office in medical technology in 2024, reflecting sustained growth in device advancements.

Key Market Players

• Boston Scientific Corporation
• Medtronic PLC
• Abbott Laboratories Inc.
• Nevro Corp.
• Liva Nova PLC
• Axonics Modulation Technologies Inc.
• Neuropace Inc.
• EndoStim Inc.
• NDI Medical LLC
• Neuronetics Inc

Report Scope:

In this report, the Global Neurostimulation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurostimulation Devices Market, By Type:

• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Others

Neurostimulation Devices Market, By Application:

• Pain Management
• Hearing Loss
• Urinary Incontinence
• Parkinson's Disease
• Epilepsy
• Others

Neurostimulation Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Neurostimulation Devices Market.

Available Customizations:

Global Neurostimulation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Neurostimulation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Others)
  • 5.2.2. By Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Neurostimulation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neurostimulation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Neurostimulation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Neurostimulation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Neurostimulation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Neurostimulation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. France Neurostimulation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Neurostimulation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Neurostimulation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Neurostimulation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Neurostimulation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Neurostimulation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Neurostimulation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Neurostimulation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Neurostimulation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Neurostimulation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. Middle East & Africa Neurostimulation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Neurostimulation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Neurostimulation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Neurostimulation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. South America Neurostimulation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Neurostimulation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Neurostimulation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Neurostimulation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Neurostimulation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic PLC
• 15.3. Abbott Laboratories Inc.
• 15.4. Nevro Corp.
• 15.5. Liva Nova PLC
• 15.6. Axonics Modulation Technologies Inc.
• 15.7. Neuropace Inc.
• 15.8. EndoStim Inc.
• 15.9. NDI Medical LLC
• 15.10. Neuronetics Inc.

16. Strategic Recommendations

17. About Us & Disclaimer